Stephen Bardin's most recent trade in CalciMedica Inc was a trade of 20,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CalciMedica Inc | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| CalciMedica Inc | Stephen Bardin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 24 Jun 2025 | 2,000 | 3,000 | - | 1.5 | 3,005 | Common Stock |
| CalciMedica Inc | Stephen Bardin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 30 May 2025 | 1,000 | 41,000 | - | 1.7 | 1,690 | Common Stock |
| CalciMedica Inc | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 130,000 | 130,000 | - | - | Employee Stock Option (Right to Buy) | |
| ATAI Life Sciences N.V. | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 600,000 | 600,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 350,000 | 350,000 | - | - | Restricted Stock Unit |